First human trial begins for potential Anti-Aging pill
Knowledge-focused
Recruiting now
This is a first-in-human study to check the safety and side effects of a new oral drug called MIB-725. It will be given in single, increasing doses to 32 healthy adults to see how their bodies react and process it. The main goal is to find a safe dose range for future studies tha…
Phase: PHASE1 • Sponsor: Metro International Biotech, LLC • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:37 UTC